Hemagen Diagnostics Stock Market Value
| HMGN Stock | USD 0.0002 0.00 0.00% |
| Symbol | Hemagen |
Hemagen Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hemagen Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hemagen Diagnostics.
| 01/19/2025 |
| 01/14/2026 |
If you would invest 0.00 in Hemagen Diagnostics on January 19, 2025 and sell it all today you would earn a total of 0.00 from holding Hemagen Diagnostics or generate 0.0% return on investment in Hemagen Diagnostics over 360 days. Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwid... More
Hemagen Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hemagen Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hemagen Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1156 | |||
| Maximum Drawdown | 100.0 |
Hemagen Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemagen Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hemagen Diagnostics' standard deviation. In reality, there are many statistical measures that can use Hemagen Diagnostics historical prices to predict the future Hemagen Diagnostics' volatility.| Risk Adjusted Performance | 0.1015 | |||
| Jensen Alpha | 1.49 | |||
| Total Risk Alpha | 0.1446 | |||
| Treynor Ratio | 8.2 |
Hemagen Diagnostics Backtested Returns
Hemagen Diagnostics is out of control given 3 months investment horizon. Hemagen Diagnostics holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13 % return per unit of risk over the last 3 months. We were able to analyze and collect data for sixteen different technical indicators, which can help you to evaluate if expected returns of 1.59% are justified by taking the suggested risk. Use Hemagen Diagnostics Standard Deviation of 12.31, risk adjusted performance of 0.1015, and Market Risk Adjusted Performance of 8.21 to evaluate company specific risk that cannot be diversified away. Hemagen Diagnostics holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.18, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Hemagen Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Hemagen Diagnostics is expected to be smaller as well. Use Hemagen Diagnostics variance and kurtosis , to analyze future returns on Hemagen Diagnostics.
Auto-correlation | 0.00 |
No correlation between past and present
Hemagen Diagnostics has no correlation between past and present. Overlapping area represents the amount of predictability between Hemagen Diagnostics time series from 19th of January 2025 to 18th of July 2025 and 18th of July 2025 to 14th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hemagen Diagnostics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Hemagen Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Hemagen Diagnostics lagged returns against current returns
Autocorrelation, which is Hemagen Diagnostics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hemagen Diagnostics' pink sheet expected returns. We can calculate the autocorrelation of Hemagen Diagnostics returns to help us make a trade decision. For example, suppose you find that Hemagen Diagnostics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hemagen Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hemagen Diagnostics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hemagen Diagnostics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hemagen Diagnostics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Hemagen Diagnostics Lagged Returns
When evaluating Hemagen Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hemagen Diagnostics pink sheet have on its future price. Hemagen Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hemagen Diagnostics autocorrelation shows the relationship between Hemagen Diagnostics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Hemagen Diagnostics.
Regressed Prices |
| Timeline |
Pair Trading with Hemagen Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hemagen Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemagen Diagnostics will appreciate offsetting losses from the drop in the long position's value.Moving together with Hemagen Pink Sheet
| 0.73 | CUB | Lionheart Holdings | PairCorr |
| 0.7 | LION | Lionsgate Studios Holding | PairCorr |
| 0.8 | JNJ | Johnson Johnson Earnings Call This Week | PairCorr |
Moving against Hemagen Pink Sheet
| 0.91 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.83 | MSFT | Microsoft | PairCorr |
| 0.8 | HPQ | HP Inc | PairCorr |
| 0.58 | DOX | Amdocs | PairCorr |
| 0.35 | T | ATT Inc | PairCorr |
The ability to find closely correlated positions to Hemagen Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hemagen Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hemagen Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hemagen Diagnostics to buy it.
The correlation of Hemagen Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hemagen Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hemagen Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hemagen Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Hemagen Pink Sheet
Hemagen Diagnostics financial ratios help investors to determine whether Hemagen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemagen with respect to the benefits of owning Hemagen Diagnostics security.